Inhalation device
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
FIG. 1 is a top plan view of the inhalation device showing my new design;
FIG. 2 is a bottom plan view thereof;
FIG. 3 is a front perspective view showing the top and left side thereof;
FIG. 4 is a side elevational view showing the left side thereof;
FIG. 5 is a side elevational view showing the right side thereof;
FIG. 6 is a front view thereof;
FIG. 7 is a rear elevational view thereof;
FIG. 8 is a top plan view thereof with the mouthpiece cover removed;
FIG. 9 is a front perspective view showing the top and left side thereof with the mouthpiece cover removed;
FIG. 10 is a side elevational view showing the left side thereof with the mouthpiece cover removed;
FIG. 11 is a side elevational view showing the right side thereof with the mouthpiece cover removed; and,
FIG. 12 is a front view thereof with the mouthpiece cover removed.
Type: Grant
Filed: Oct 10, 1996
Date of Patent: Feb 24, 1998
Assignee: Glaxo Group Limited (London)
Inventor: Gregor John McLennan Anderson (Ware)
Primary Examiner: Stella Reid
Law Firm: Bacon & Thomas
Application Number: 0/60,921
International Classification: 2404;